Abstract
Single nucleotide polymorphism (SNP) is the simplest form of DNA variation among individuals. These simple changes can be of transition or transversion type and they occur throughout the genome at a frequency of about one in 1,000 bp. They may be responsible for the diversity among individuals, genome evolution, the most common familial traits such as curly hair, interindividual differences in drug response, and complex and common diseases such as diabetes, obesity, hypertension, and psychiatric disorders. SNPs may change the encoded amino acids (nonsynonymous) or can be silent (synonymous) or simply occur in the noncoding regions. They may influence promoter activity (gene expression), messenger RNA (mRNA) conformation (stability), and subcellular localization of mRNAs and/or proteins and hence may produce disease. Therefore, identification of numerous variations in genes and analysis of their effects may lead to a better understanding of their impact on gene function and health of an individual. This improved knowledge may provide a starting point for the development of new, useful SNP markers for medical testing and a safer individualized medication to treat the most common devastating disorders. This will revolutionize the medical field in the future. To illustrate the effect of SNPs on gene function and phenotype, this minireview focuses on evidences revealing the impact of SNPs on the development and progression of three human eye disorders (Norrie disease, familial exudative vitreoretinopathy, and retinopathy of prematurity) that have overlapping clinical manifestations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brookes, A. J. (1999) The essence of SNPs. Gene 234, 177–186.
Halushka, M. K., Fan, J. B., Bentley, K., Hsie, L., Shen, N. P., Weder, A., Cooper, R., Lipshutz, R. and Chakravarti, A. (1999) Patterns of single nucleotide polymorphisms in candidate genes for blood pressure homeostasis. Nat. Genet. 22, 239–247.
Martin, N., Boomsma, D. and Machin, G. (1997) A twin pronged attacks on complex traits. Nat. Genet. 17, 387–392.
Krawezak, M., Reiss, J. and Cooper, D. N. (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90, 41–54.
Lohrer, H. D. and Tangen, U. (2000) Investigations into the molecular effects of single nucleotide polymorphism. Pathobiology 68, 283–290.
LeVan, T. D., Bloom, J. W., Bailey, T. J., Karp, C. L., Halonen, M., Martinez, F. D. and Vercelli, D. (2001) A common single nucleotide polymorphism in the CD 14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 167, 5838–5844.
Shastry, B. S. (2007) SNPs in disease gene mapping, medicinal drug development and evolution. J. Hum. Genet. 52, 871–880.
Shastry, B. S. (2006) Pharmacogenetics and the concept of individualized medicine. Pharmacogenomics J. 6, 16–21.
Shastry, B. S. (2005) Genetic diversity and new therapeutic concepts. J. Hum. Genet. 50, 321–328.
Shastry, B. S. (2004) Role of SNP/haplotype map in gene discovery and drug development: an overview. Drug Dev. Res. 62, 143–150.
Warburg, M. (1966) Norrie’s disease: a congenital progressive oculo-acustico-cerebral degeneration. Acta Ophthalmol. 89, 1–147.
Sims, K. B., Irvine, A. R. and Good, W. V. (1997) Norrie disease in a family with a manifesting female carrier. Arch. Ophthalmol. 115, 517–519.
Chen, Z. Y., Battinelli, E. M., Woodruff, G., Young, I., Breakefield, X. O. and Craig, I. W. (1993) Characterization of mutation within the NDP gene in a family with a manifesting female carrier. Hum. Mol. Genet. 2, 1727–1729.
Shastry, B. S., Hiraoka, M., Trese, D. C. and Trese, M. T. (1999) Norrie disease and exudative vitreoretinopathy in families with affected female carries. Eur. J. Ophthalmol. 9, 238–242.
Berger, W., Meindl, A., van de Pool, T. J., Cremers, F. P., Ropers, H.-H., Doerner, C., Monaco, A., Bergen, A. A., Lebo, R., Warburg, M., Zergollern, L., Lorenz, B., Gal, A., Bleeker-Wagemakers, E. M. and Meitinger, T. (1992) Isolation of a candidate gene for Norrie’s disease by positional cloning. Nat. Genet. 1, 199–203.
Chen, Z. Y., Hendricks, R. W., Jobling, M. T. A., Powell, J. F., Breakefield, X. O., Sims, K. B. and Criag, I. W. (1992) Isolation and characterization of a candidate gene for Norrie disease. Nat. Genet. 1, 204–208.
Kenyon, J. R. and Criag, I. W. (1999) Analysis of the 5’-regulatory region of the human Norrie disease gene: evidence that non-translated CT dinucleotide repeat in exon-1 has a role in controlling expression. Gene 277, 181–188.
Katoh, M. and Katoh, M. (2005) Comparative genomics on Norrie disease gene. Int. J. Mol. Med. 15, 885–889.
Meindl, A., Berger, W., Meitinger, T., van de Pool, D., Achatz, H., Dorner, C., Haasemann, M., Hellebrand, G. A., Cremers, F. and Ropers, H.-H. (1992) Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domains of mucins. Nat. Genet. 2, 139–143.
Chen, Z. Y., Bettinelli, E. M., Hendricks, R. W., Powell, J. F., Middleton-Price, H., Sims, K. B., Breakefield, X. O. and Craig, I. W. (1993) Norrie disease gene: characterization of deletions and possible functions. Genomics 16, 533–535.
Meitinger, T., Meindl, A., Bork, P., Rost, B., Sander, C., Haasemann, M. and Markrn J. (1993) Molecular modeling of Norrie disease protein predicts a cystine knot growth factor tertiary structure. Nat. Genet. 5, 376–380.
McDonald, N. G. and Hendrickson, W. A. (1993) A structural superfamily of growth factors containing a cystine knot motif. Cell 73, 421–424.
Perez-Vilar, J. and Hill, R. L. (1997) Norrie disease protein (norrin) forms disulphide linked oligomers. J. Biol. Chem. 272, 33410–33415.
Luhmann, U. F., Meunier, D., Shi, W., Luttges, A., Pfarrer, C., Fundele, R. and Berger, W. (2005) Fetal loss in homozygous mutant Norrie disease mice: a new role of norrin in reproduction. Genesis 42, 253–262.
Berger, W., van de Pool, D., Bachner, D., Oerlemans, F., Winkens, H., Hameister, H., Wieringa, B., Hendricks, W. and Roper, H.-H. (1996) An animal model for Norrie disease: gene targeting of mouse ND gene. Hum. Mol. Genet. 5, 51–59.
Xu, O., Wang, Y. S., Dabdoub, A., Smallwood, P. M., Williams, J., Woods, C., Kelley, M. W., Jiang, L., Tasman, W., Zhang, K. and Nathans, J. (2004) Vascular development in the retina and inner ear: control by norrin and frizzled 4, a high affinity ligand receptor pair. Cell 116, 883–895.
Luhmann, U. F., Lin, J., Acar, N., Lammel, S., Feils, S., Grimm, C., Seeliger, M. W., Hammes, H. P. and Berger, W. (2005) Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest. Ophthalmol. Vis. Sci. 46, 3372–3382.
Hartzer, M. K., Cheng, M., Liu, X. and Shastry, B. S. (1999) Localization of the Norrie disease gene mRNA by in situ hybridization. Brain Res. Bull. 49, 355–358.
Rehm, H. L., Zhang, D. S., Brown, M. C., Burgess, B., Halpin, C., Berger, W., Morton, C., Corey, D. P. and Chen, Z., Y. (2002) Vascular defects and sensorineural deafness in a mouse model of Norrie disease. J. Neurosci. 22, 4286–4292.
Shastry, B. S. and Hiraoka, M. (2000). Molecular genetics of familial exudative vitreoretinopathy and Norrie disease. Curr. Genomics 1, 259–269.
Schuback, D. E., Zheng, Y. C., Criag, I. W., Breakefield, X. O. and Sims, K. B. (1995) Mutations in the Norrie disease gene. Hum. Mutat. 5, 285–292.
Lev, D., Weigi, Y., Hasan, M., Gak, E., Davidovich, M., Vinkler, C., Leshinsky-Silver, E., Lerman-Sagie, T. and Watemberg, N. (2007) A novel missense mutation in the NDP gene in a child with Norrie disease and severe neurological involvement including infantile spasms. Am. J. Med. Genet. 143, 921–924.
Yamada, K., Limprasert, P., Ratanasukon, M., Tengtrisorn, S., Yingchareonpukdee, J., Vasiknanonte, P., Kitaoka, T., Ghadami, M., Niikawa, N. and Kishino, T. (2001) Two Thai families with Norrie disease (ND): association of two novel missense mutations with severe ND phenotype, seizures and a manifesting carrier. Am. J. Med. Genet. 100, 52–55.
Kondo, H., Qin, M., Kusaka, S., Tahira, T., Hasebe, H., Hayashi, H., Uchio, E. and Hayashi, K. (2007) Novel mutations in Norrie disease gene in Japanese patients with Norrie disease and familial exudative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 48, 1276–1282.
Fuchs, S., van de Pool, D., Beudt, U., Kellner, U., Meire, F., Berger, W. and Gal, A. (1996) Three novel and two recurrent mutations of the Norrie disease gene in patients with Norrie syndrome. Hum. Mutat. 8, 85–88.
Strasberg, P, Liede, H. A., Stein, T., Warren, I., Sutherland, J. and Ray, P. N. (1995) A novel mutation in the Norrie disease gene predicted to disrupt the cystine knot growth factor motif. Hum. Mol. Genet. 4, 2179–2180.
Meindl, A., Lorenz, B., Achatz, H., Hellebrand H., Schmitz-Vakkenberg, P. and Meitinger, T. (1995) Missense mutation in the NDP gene in patients with a less severe course of Norrie disease. Hum. Mol. Genet. 4, 489–490.
Fuentes, J. J., Volpini, V., Fernandez-Toral, F., Coto, E. and Estivill, X. (1993) Identification of two new missense mutations (K58N and R121Q) in the Norrie disease (ND) gene in two Spanish families. Hum. Mol. Genet. 2, 1953–1955.
Torrente, I., Mangino, M., Gennarelli, M., Novelli, G., Giannotti, A., Vadala, P. and Dallapiccola, B. (1997) Two new missense mutations (A105T and C110G) in the Norrie gene in two Italian families with Norrie disease and familial exudative vitreoretinopathy. Am. J. Med. Genet. 72, 242–244.
Walker, J. L., Dixon, J., Fenton, C. R., Hungerford, J., Lynch, S. A., Stenhouses, S. A. K., Christian, A. and Craig, I. W. (1997) Two new mutations in exon 3 of the NDP gene: S73X and S101F associated with severe and less severe ocular phenotypes respectively. Hum. Mutat. 9, 53–56.
Allen, R. C., Russell, S. R., Streb, L. M., Alsheikheh, A. and Stone, E. M. (2006) Phenotypic heterogeneity associated with a novel mutation (Gly 112 Glu) in the Norrie disease protein. Eye 20, 234–241.
Wang, F., Goldberg, M. F. and Hao, Y. (1993) Identification of a nonsense mutation at codon 128 of the Norrie’s disease gene in a male infant. Arch. Ophthalmol. 111, 1553–1557.
Drenser, K. A., Fecko, A., Dailey, W. and Trese, M. T. (2007) A characteristic phenotypic retinal appearance in Norrie disease. Retina 27, 243–246.
Berger, W., van de Pool, D., Warburg, M., Gal, A., Bleeker-Wagemakers, L., de Silva, H., Meindl, A., Meitinger, T., Cremers, F. and Ropers, H-H. (1992) Mutations in the candidate gene for Norrie disease. Hum. Mol. Genet. 1, 461–465.
Isashiki, Y., Ohba, N., Yanagita, T., Hokita, N., Doi, N., Nakagawa, M., Ozawa, M. and Kuroda, N. (1995) Novel mutation at the initiation codon in the Norrie disease gene in two Japanese families. Hum. Genet. 95, 105–108.
Joos, K. M., Kimura, A. E., Vandenburgh, K., Bartley, J. A. and Stone E. M. (1994) Ocular findings associated with a cys39Arg mutation in the Norrie disease gene. Arch. Ophthalmol. 112, 1574–1579.
Plager, D. A., Orgel, I. K., Forest, D. E., Hartzer, M., Trese, M. T. and Shastry, B. S. (1992) X-linked recessive familial exudative vitreoretinopathy. Am. J. Ophthalmol. 114, 145–148.
Fullwood, P., Jones, J., Bundey, S., Dudgeon, J., Fielder, A. R. and Kilpatrick, M. W. (1993) X-linked exudative vitreoretinopathy: clinical features and genetic linkage analysis. Br. J. Ophthalmol. 77, 168–170.
Clement, F., Beckford, C. A., Corral, A. and Jimenez, R. (1995) X-linked familial exudative vitreoretinopathy. Retina 15, 141–145.
Van Nouhuys, C. E. (1982) Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina. Doc. Ophthalmol. 54, 1–414.
Shastry, B. S. and Trese, M. T. (1997) Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity. Am. J. Med. Genet. 69, 217–218.
De Crecchio, G., Simonelli, F., Nunziata, G., Mazzeo, S., Greco, G. M., Rinaldi, E., Ventruto, V., Ciccodicola, A., Miano, M. G., Testa, F., Curci, A., D’Urso, M., Rinaldi, M. M., Cavaliere, M. L. and Castelluccio, P. (1998) Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. Clin. Genet. 54, 315–320.
Shastry, B. S., Liu, X., Hejtmancik, J. F., Plager, D. A. and Trese, M. T. (1997) Evidence for genetic heterogeneity in X-linked familial exudative vitreoretinopathy. Genomics 44, 247–248.
Bamashmus, M. A., Downey, L. M., Inglehearn, C. F., Gupta, S. R. and Mansfield, D. C. (2000) Genetic heterogeneity in familial exudative vitreoretinopathy: exclusion of the EVR1 locus on chromosome 11q in a large autosomal dominant pedigree. Br. J. Ophthalmol. 84, 358–363.
Chen, Z. Y., Bettinelli, E. M., Fielder, A., Bundey, S., Sims, K., Breakefield, X. O. and Craig, I. W. (1993) A mutation in the Norrie disease gene associated with X-linked familial exudative vitreoretinopathy. Nat. Genet. 5, 180–183.
Shastry, B. S., Hejtmancik, J. F., Plager, D. A., Hartzer, M. T. and Trese, M. T. (1995) Linkage and candidate gene analysis of X-linked familial exudative vitreoretinopathy. Genomics 27, 341–344.
Shastry, B. S., Hejtmancik, J. F. and Trese, M. T. (1997) Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy. Hum. Mutat. 9, 396–401.
Fuchs, S., Kellner, U., Wedemann, H. and Gal, A. (1995) Missense mutation (Arg121Trp) in the Norrie disease gene associated with X-linked exudative vitreoretinopathy. Hum. Mutat. 6, 257–259.
Drenser, K. A., Dailey, W., Capone, A. and Trese, M. T. (2006) Genetic evaluation to establish the diagnosis of X-linked familial exudative vitreoretinopathy. Ophthalmic Genet. 27, 75–78.
Johnson, K., Mintz-Hittner, H. A., Conley, Y, P. and Ferrell, R. E. (1996) X-linked exudative vitreoretinopathy caused by an arginine to leucine substitution (R121L) in the Norrie disease protein. Clin. Genet. 50, 113–115.
Riveiro-Alvarez, R., Trujillo-Tiebas, M. J., Gimenez-Pardo, A., Garcia-Hoyos, M., Cantalapiedra, D., Lorda-Sanchez, I., de Alba, M. R., Ramos, C. and Ayuso, C. (2005) Genotype-phenotype variations in five Spanish families with Norrie disease or X-linked FEVR. Mol. Vis. 11, 705–712.
Wu, W.-C., Drenser, K., Trese, M. T., Capone, A. and Dailey, W. (2007) Retinal genotype-phenotype correlation of pediatric patients expressing mutations in the Norrie disease gene. Arch. Ophthalmol. 125, 225–230.
Li, Y., Fuhrmann, C., Schwinger, E., Gal, A. and Laqua, H. (1992) The gene for autosomal dominant exudative vitreoretinopathy (Criswick-Schepens) is on the long arm of chromosome 11. Am. J. Ophthalmol. 113, 712–713.
Muller, B., Orth, U., van Nouhuys, C. E., Durigneau, C., Fuhrmann, C., Schwinger, E., Laqua, H. and Gal, A. (1994) Mapping of the autosomal dominant exudative vitreoretinopathy locus (EVR1) by multipoint linkage analysis in four families. Genomics 20, 317–319.
Price, S. M., Periam, N., Humphries, A., Woodruff, G. and Trembath, R. C. (1996) Familial exudative vitreoretinopathy linked to D11S533 in a large Asian family with consanguinity. Ophthalmic Genet. 17, 53–57.
Shastry, B. S., Hejtmancik, J. F., Hiraoka, M., Ibaraki, N., Okubo, Y., Okubo, A., Han, D. P. and Trese, M. T. (2000) Linkage and candidate gene analysis of autosomal dominant familial exudative vitreoretinopathy. Clin. Genet. 58, 329–332.
Kondo, H., Ohno, K., Tahira, T., Hayashi, H., Oshima, K. and Hayashi, K. (2001) Delineation of the critical interval for the familial exudative vitreoretinopathy gene by linkage and haplotype analysis. Hum. Genet. 108, 368–375.
Downey, L. M., Keen, T. J., Roberts, E., Mansfield, D. C., Bamashmus, M. and Inglehearn, C. F. (2001) A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. Am. J. Hum. Genet. 68, 778–781.
Qin, M., Hayashi, H., Oshima, K., Tahira, T., Hayashi, K. and Kondo, H. (2005) Complexity of genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD 4 genes. Hum. Mutat. 26, 104–112.
Kondo, H., Hayashi, H., Oshima, K., Tahira, T. and Hayashi, K. (2003) Frizzled 4 gene (FZD 4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity. Br. J. Ophthalmol. 87, 1291–1295.
Yoshida, H., Arita, R., Yoshida, A., Tada, H., Emori, A., Noda, Y., Nakao, S., Fujisawa, K. and Ishibashi, T. (2004) Novel mutation in FZD 4 gene in a Japanese pedigree with familial exudative vitreoretinopathy. Am. J. Ophthalmol. 138, 670–671.
Omoto, S., Hayashi, T., Kitahara, K., Takeuchi, T. and Ueoka, Y. (2004) Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD 4 mutations (H69Y and C181R). Ophthalmic Genet. 25, 81–90.
Robitaille, J., MacDonald, M. L. E., Kaykas, A., Sheldahi, L. C., Zeisler, J., Dube, M. P., Zhang, L. H., Singaraja, R. R., Guernsey, D. L., Zheng, B., Siebert, L. F., Hoskin-Mott, A., Trese, M. T., Pimstone, S. N., Shastry, B. S., Moon, R. T., Hayden, M. R., Goldberg, Y. P. and Samuels, M. E. (2002) Mutant frizzled 4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat. Genet. 32, 326–330.
Toomes, C., Bottomley, H. M., Scott, S., Mackey, D. A., Craig, J. E., Appukuttan, B., Stout, J. T., Faxel, C. J., Zhang, K., Black, G. C. M., Fryer, A., Downey, L. M. and Inglehearn, C. F. (2004) Spectrum and frequency of FZD 4 mutations in familial exudative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 45, 2083–2090.
Toomes, C., Bottomley, H. M., Jackson, R. M., Towns, K. V., Scott, S., Mackey, D. A., Craig, J. E., Jiang, L., Yang, Z., Trembath, R., Woodruff, G., Gregory-Evans, C. Y., Gregory-Evans, K., Parker, M. J., Black, G. C. M., Downey, L. M., Zhang, K. and Inglehearn, C. F. (2004) Mutations in LRP5 or FZD 4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am. J. Hum. Genet. 74, 721–730.
Huang, H.-C. and Klein, P. S. (2004) The frizzled family: receptors for multiple signal transduction pathways. Genome Biol. 5, 234–239.
De Iongh, R. U., Abad, H. E. and Hime, G. R. (2006) Wnt/frizzled signaling in eye development and disease. Frontiers Biosci. 11, 2442–2464.
Pinson, K. L., Brennan, J., Monkley, S., Avery, B. J. and Sharnes, W. C. (2000) An LDL – receptor related protein mediates Wnt signaling in mice. Nature 407, 535–538.
Kykas, A., Yang-Snyder, J., Aeroux, M., Shah, K. V., Bouvier, M. and Moon, R. T. (2004) Mutant frizzled 4 associated with vitreoretinopathy traps wild-type frizzled in the endoplasmic reticulum by oligomerization. Nat. Cell. Biol. 6, 52–58.
Jiao, X., Ventruto, V., Trese, M. T., Shastry, B. S. and Hejtmancik, J. F. (2004) Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. Am. J. Hum. Genet. 75, 878–884.
Downey, L. M., Bottomley, H. M., Sheridan, E., Ahmed, M., Gilmour, D. F., Inglehearn, C. F., Reddy, A., Agrawal, A., Brodbury, J. and Toomes, C. (2006) Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5. Br. J. Ophthalmol. 90, 1163–1167.
Hey, P. J., Twells, R. C., Phillips, M. S., Yusuke, N., Brown, S. D., Kawaguchi, Y., Cox, R., Gouchun, X., Dugan, V., Hammond, H., Metzker, M. L., Todd, J. A. and Hess, J. F. (1998) Cloning of a novel member of the low-density lipoprotein receptor family. Gene 216, 103–111.
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M. and Wang, H. et al. (2001) LDL receptor related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513–523.
Plamer, E. A. (1996) The continuing threat of retinopathy of prematurity. Am. J. Ophthalmol. 122, 420–423.
Gilbert, C., Rahi, J., Eckstein, M., O’Sullivan, J. and Foster, A. (1997) Retinopathy of prematurity in middle-income countries. Lancet 350, 12–14.
Shastry, B. S., Pendergast, S. D., Hartzer, M.K., Liu, X. and Trese, M. T. (1997) Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch. Ophthalmol. 115, 651–656.
Vannay, A., Dunai, G., Banyasz, I.,Szabo, M., Vamos, R., Treszl, A., Hajdu, J., Tulassay, T. and Vasarhelyi, B. (2005) Association of genetic polymorphisms of vascular endothelial growth factor and risk of proliferative retinopathy of prematurity. Pediatr. Res. 57, 396–398.
Cooke, R. W., Drury, J. A., Mountford, R. and Clark, D. (2004) Genetic polymorphism and retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 45, 1712–1715.
Haider, M. Z., Devarajan, L. V., Al-Essa, M. and Kumar, H. A. (2002) A C597 → A polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in premature Kuwaiti infants. J. Biomed. Sci. 9, 365–370.
Haider, M. Z., Devarajan, L.V., Al-Essa, M. and Kumar, H. (2002) Angiotensin – converting enzyme gene insertion/deletion polymorphism in Kuwaiti children with retinopathy of prematurity. Biol. Neonate. 82, 84–88.
Talks, S. J., Ebenezer, N., Hykin, P., Adams, A., Yang, F., Schulenberg, E., Gregory-Evans, K. and Gregory-Evans, C. Y. (2001) De novo mutations in the 5’ regulatory region of the Norrie disease gene in retinopathy of prematurity. J. Med. Genet. 38, e46.
Hiraoka, M., Berinstein, D. M., Trese, M. T. and Shastry, B. S. (2001) Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J. Hum. Genet. 46, 178–181.
Hutcheson, K. A., Paluru, P. C., Bernstein, S. L., Koh, J., Rappaport, E. F., Leach, R. A. and Young, T. L. (2005) Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol. Vis. 11, 501–508.
Dickinson, J. L., Sale, M. M., Passmore, A., FitzGerald, L. M., Wheatley, C. M., Burdon, K. P., Franzco, J. E. C., Tengtrisorn, S., Franzco, S. M. C., Franzco, H. M. and Franzco, D. A. M. (2006) Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. Clin Exp. Ophthalmol. 34, 682–688.
MacDonald, M. L. E., Goldberg, Y. P., MacFarlane, J., Samuels, M. E., Trese, M. T. and Shastry, B. S. (2005) Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity. Clin Genet. 67, 363–366.
Bizzarro, M. J., Hussain, N., Jonsson, B., Feng, R., Ment, L. R., Gruen, J. F., Zhang, H. and Bhandari, V. (2006) Genetic susceptibility to retinopathy of prematurity. Pediatrics 118, 1858–1863.
Holmstrom, G., Van Wijngaarden, P., Coster, D. J. and Williams, K. A. (2007) Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. Br. J. Ophthalmol. 97, 1704–1708.
Lang, D. M., Backledge, J. and Arnold, R. W. (2005) Is specific race a retinopathy prematurity risk factor. Arch. Pediatr. Adolesc. Med. 159, 771–773.
Floyd, B. N., Leske, D. A., Wren, S. M., Mookadam, M., Fautsch, M. P. and Holmes, J. M. (2005) Differences between rat strains in models of retinopathy of prematurity. Mol. Vis. 11, 524–530.
Van Wijngaarden, P., Coster, D. J., Brereton, H. M., Gibbins, I. L. and Williams, K. A. (2005) Strain-dependent differences in oxygen-induced retinopathy of prematurity in the inbred rats. Invest. Ophthalmol. Vis. Sci. 46, 1445–1452.
Shastry, B. S. (2007) Assessment of the contribution of insulin-like growth factor I receptor 3174 G → A polymorphism to the progression of advanced retinopathy of prematurity. Eur. J. Ophthalmol. 17, 950–953.
Shastry, B. S. and Qu, X. (2007) Lack of association of the VEGF gene promoter (–634G → C and –460C → T) polymorphism and the risk of advanced retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 245, 741–743.
Balogh, A., Derzbach, L., Vannay, A. and Vasarhelyi, B. (2006) Lack of association between insulin-like growth factor I 3174G → A polymorphism and retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 244, 1035–1038.
Kwinta, P., Mitkowska, Z., Tomasik., T., Bik-Multanowski, M. and Pietrzyk, J. J. (2004) Vascular endothelial growth factor gene polymorphism and the risk of retinopathy of prematurity. Pediatr. Res. 56, 488.
Kim, J. H., Yu, Y. S., Kim, J. and Park, S. S. (2002) Mutation of the Norrie disease gene in Korean ROP infants. Korean J. Ophthalmol. 16, 93–96.
Dhingra, S., Shears, D. J., Blake, V., Stewart, H. and Patel, C. K. (2006) Advanced bilateral persistent fetal vasculature associated with a novel mutation in the Norrie gene. Br. J. Ophthalmol. 90, 1324–1325.
Black, G. C. M., Perveen, R., Bonshek, R., Cahill, M., Clayton-Smith, J., Lloyd, C. and McLeod, D. (1999) Coats’ disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum. Mol. Genet. 8, 2031–2035.
Takahashi-Yanaga, F. and Sasaguri, T. (2007) The Wnt/β-catenin signaling pathway as a target in drug discovery. J. Pharmacol. Sci. 104, 293–302.
Moon, R. T., Kohn, A. D., DeFerrari, G. V. and Kaykas, A. (2004) Wnt and β-catenin signaling: diseases and therapies. Nat. Rev. Genet. 5, 691–701.
Smallwood, P. M., Williams, J., Xu, Q., Leahy, D. J. and Nathans, J. (2007) Mutation analysis of norrin-frizzled 4 recognition. J. Biol. Chem. 282, 4057–4068.
Chen, J.-M., Ferec, C. and Cooper, D. N. (2006) A systematic analysis of disease-associated variants in the 3’ regulatory regions of human protein coding genes: general principles and overview. Hum. Genet. 120, 1–21.
Wong, P. M. C., Yuan, Q., Chen, H., Sultzer, B. M. and Chung, S.-W. (2001) A single point mutation at the 3’ untranslated region of Ran mRNA leads to profound changes in lipopolysaccharide endotoxin mediated responses. J. Biol. Chem. 276, 33129–33138.
Zhang, W., Duan, S., Kistner, E. O., Bleibel, W. K., Huang, R. S., Clark, T. A., Chen, T. X., Schweitzer, A. C., Blume, J. E., Cox, N. J. and Dolan, M. E. (2008) Evaluation of genetic variation contributing to differences in gene expression between populations. Am. J. Hum. Genet. 82, 631–640.
Qin, M., Kondo, H., Tahira, T. and Hayashi, K. (2008) Moderate reduction of norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy. Hum. Genet. 122, 615–623.
Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B.-H. J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., Lang, R. A., Karsenty, G. and Chan, L. (2002) Cbfa1 – independent decrease in osteoblast proliferation, osteopenia and persistent embryonic eye vascularization in mice deficient in LRP5, a Wnt co-receptor. J. Cell Biol. 157, 303–314.
Xia, C. H., Liu, H., Cheung, D., Wang, M., Cheng, C., Du, X., Chang, B., Beutler, B. and Gong, X. (2008) A model for familial exudative vitreoretinopathy caused by LRP5 mutations. Hum. Mol. Genet. 17, 1605–1612.
Acknowledgements
My apologies to those whose work or original publications could not be cited in this short article because of space limitations.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC 2003
About this protocol
Cite this protocol
Shastry, B.S. (2009). SNPs: Impact on Gene Function and Phenotype. In: Komar, A. (eds) Single Nucleotide Polymorphisms. Methods in Molecular Biology™, vol 578. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-411-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-60327-411-1_1
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-410-4
Online ISBN: 978-1-60327-411-1
eBook Packages: Springer Protocols